11th Annual North Carolina Research Triangle Pulmonary Hypertension Symposium

Duke University and University of North Carolina’s 11th Annual North Carolina Research Triangle Pulmonary Hypertension Symposium partnered with PHA through the Building Medical Education in PH program.

Date

Friday, November 1, 2019

Time

Registration & breakfast: 7-8 a.m.
Symposium: 8 a.m.-4:00 p.m.

Location

Durham Convention Center
301 W. Morgan Street
Durham, NC 27701 (map)

Agenda and more information

Course Overview

This is a one-day symposium with a focus on fortifying the knowledge base of physicians and other allied health professionals treating Pulmonary Arterial Hypertension, keeping them abreast of the ever-changing diagnostic and treatment paradigms. The symposium will address issues as it relates to appropriate diagnostic procedures, proper treatment choices, and timing of referral for more advanced care to pulmonary hypertension centers for healthcare providers at the front lines of screening fo and diagnosign Pulmonary Arterial Hypertension (PAH). 

Course Directors

H. James Ford, MD
Associate Professor of Medicine
Director, Pulmonary Hypertension Program
Division of Pulmonary and Critical Care Medicine
University of North Carolina at Chapel Hill

Terry Fortin, MD
Associate Professor of Medicine
Co-Director, Pulmonary Vascular Disease Center
Division of Cardiology
Duke University Medical Center 

Invited Faculty

Talal I. Dahhan, MD, MSEd
Assistant Professor of Medicine
Pulmonary Vascular Disease Center
Division of Pulmonary, Allergy, and Critical Care Medicine
Duke University Medical Center

John Carroll Haney, MD, MPH
Assistant Professor of Surgery
Division of Cardiovascular and Thoracic Surgery
Department of Surgery | Duke University 

Anna Hemnes, MD
Associate Professor of Medicine
Assistant Director Pulmonary Vascular Center
Division of Allergy, Pulmonary, and Critical Care Medicine
Vanderbilt University Hypertension Reference Center

Marc Humbert, MD
Professor of Medicine
University of South Paris
Director, Department of Pulmonology and Intensive Care
French Pulmonary Hypertension Reference Center
Hôpital Bicêtre
Assistance Publique Hôpitaux de Paris
Le Kremlin Bicêtre, France

Sheila Krishnan, DO
Assistant Professor of Medicine
Pulmonary Hypertension Program
University of North Carolina at Chapel Hill

Barbara LeVarge, MD
Assistant Professor of Medicine
Associate Director, Pulmonary Hypertension Program
University of North Carolina at Chapel Hill 

Kishan Parikh, MD
Assistant Professor of Medicine
Division of Cardiology
Duke University Medical Center

Sudarshan Rajagopal, MD, PhD
Assistant Professor of Medicine
Co-Director, Duke Pulmonary Vascular Disease Center
Division of Cardiology
Duke University Medical Center

Lisa Rose-Jones, MD
Assistant Professor of Medicine
Pulmonary Hypertension Program
University of North Carolina at Chapel Hill

Jordan Whitson, MD
Medical Instructor in the Department of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Duke University Medical Center

Target Audience

This program is designed to meet the continuing education (CE) needs of pulmonologists, cardiologists, nurses, pharmacists, and other allied healthcare professionals involved in the treatment of pulmonary hypertension.

Learning Objectives

  • Describe classification of Pulmonary Hypertension, according to the World Symposium classifications and including updates from the 6thWorld Symposium, as well as the treatment options with respect to PAH-specific therapies. 
  • Recognize and distinguish similar disease processes that may or may not respond to Pulmonary Arterial Hypertension specific therapy 
  • Identify various PH subtypes and understand their diagnosis and clinical course, particularly PH associated with hematologic disorders and portopulmonary hypertension. 
  • Risk stratify patients with pulmonary hypertension for surgical and procedural risk based upon disease severity and procedure type. 
  • Recognize the importance of right ventricular function and adaptation to the increased afterload seen in PAH. Understand that future therapies may directly target RV function and adaptability. 
  • Identify the role of clinical trials in the development of new PAH therapies, with a particular appreciation of the patient perspective as a clinical trial subject. 
  • Recognize the importance of nonpharmacologic interventions such as cardiac/pulmonary rehab. 
  • Describe the importance of screening for CTEPH and referral for definitive therapy, as well as gain knowledge on new developments in the field of CTEPH. 
  • Express how the evolving field of precision medicine applies to the current and future state of PAH diagnosis and treatment. 

Joint Accreditation Statement

This activity has been planned and implemented by the Duke University Health System Department of Clinical Education & Professional Development for the advancement of patient care. In support of improving patient care, the Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

Category 1: Duke University Health System Department of Clinical Education and Professional Development designates this activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurse CE: Duke University Health System Department of Clinical Education and Professional Development designates this activity for up to 6.5 credit hours for nurses. Nurses should claim only credit commensurate with the extent of their participation in this activity.

Pharmacists: Duke University Health System Department of Clinical Education and Professional Development designates this activity for a maximum of 6.5 ACPE credit hours. Universal Activity Numbers: JA0000655-0000-19-276-L01-P

Registration Fees*

$195: MDs and DOs
$60: Non-Physician Clinicians, Allied Health, Residents, and Fellows
$195: Industry representatives

*Registration fees include all symposium materials, breakfast, lunch and breaks.

Register Here

Accommodations and Room Rates

A block of rooms has been reserved at the Durham Marriott City Center, 201 Foster Street, Durham, NC 27701. Rooms are $149 per night, plus applicable taxes. The room block will be held until October 1, 2019 but may sell out prior to this date. To reserve your room at the conference rate, please call 1-800-228-9290 or 919-768-6000 and identify yourself as part of the 11th Annual NC Research Triangle Pulmonary Hypertension Symposium.

Cancellation Policy

All cancellation requests must be submitted in writing to Christy Darnell via email (christy.darnell@duke.edu). In the event that the program is canceled or postponed, we will not be responsible for any travel costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies, or hotels. 

After the Event

To complete all course requirements and claim continuing education credits, please do the following:

  • Complete the course evaluation.
  • Attest to your hours of completion.
  • Download your certificate.